Looks like a winner: phase2B completed in april17 with promising results from compassionate use trials- should get fast track approval for phase 3- would be interested in your opinion
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info